ESSA Pharma Balance Sheet - Quarterly (NASDAQ:EPIX)

Add to My Stocks
$3.07 $0.2 (6.12%) EPIX stock closing price Sep 18, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like ESSA Pharma, and helps in stock analysis. How cash on hand has increased or decreased is one of the many indicators used while undertaking the ESSA Pharma stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. ESSA Pharma balance sheet as at the end of 2018 Q3 indicates an asset turnover ratio of and debt to equity ratio of . Also check ESSA Pharma revenue and ESSA Pharma operating cash flow for the same period.

View and download ESSA Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Oct - Sep2018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets---1.07M---1.01M-1.08M
Total Current Assets
Property Plant & Equipment-197.67M--------
Accumulated Depreciation-108.58M--------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable-1.37M1.5M1.64M2.04M2.95M1.39M3.53M2.05M1.36M
Current Portion Long-Term Debt2.82M2.76M2.71M2.02M1.33M-----
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities--------8.35M9.21M
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt4.09M4.72M5.33M5.93M6.5M7.13M7.71M---
Non-Current Capital Leases----------
Other Long-Term Liabilities-----8.79M5.31M7.3M--
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net40.21M40.2M25.98M25.98M25.98M25.97M25.97M25.97M25.97M25.96M
Capital Surplus----------
Retained Earnings-42.09M-39.21M-34.87M-32.96M-30.79M-34.38M-26.77M-28.24M-24M-20.13M
Treasury Stock----------
Other Liabilities12.83M12.38M2.57M2.48M2.63M2.51M2.27M1.72M1.29M1.06M
Shareholders Equity10.94M13.37M-6.31M-4.49M-2.17M-5.89M1.46M-0.53M3.26M6.88M
Total Liabilities & Shareholders Equity18.51M22.33M3.43M5.6M8.4M13.73M15.98M10.4M13.66M17.47M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest ESSA Pharma stock price, and ESSA Pharma historical stock prices show the stock price movement over time, and the ESSA Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like ESSA Pharma owns and has monetary significance. EPIX assets decreased from $22.33M in 2018 Q2 to $18.51M in 2018 Q3. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case ESSA Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for EPIX stock stand at $7.57M.

ESSA Pharma Balance Sheet - Key Ratios